{"id":"https://openalex.org/W2463342811","doi":"https://doi.org/10.1176/ajp.151.11.1626","title":"Neuroendocrine and behavioral responses to intravenous m- chlorophenylpiperazine (mCPP) in depressed patients and healthy comparison subjects","display_name":"Neuroendocrine and behavioral responses to intravenous m- chlorophenylpiperazine (mCPP) in depressed patients and healthy comparison subjects","alternate_titles":[],"publication_year":1994,"publication_date":"1994-11-01","ids":{"openalex":"https://openalex.org/W2463342811","doi":"https://doi.org/10.1176/ajp.151.11.1626","mag":"2463342811","pmid":"https://pubmed.ncbi.nlm.nih.gov/7943451"},"language":"en","primary_location":{"id":"doi:10.1176/ajp.151.11.1626","doi":"https://doi.org/10.1176/ajp.151.11.1626","is_oa":false,"landing_page_url":"https://doi.org/10.1176/ajp.151.11.1626","pdf_url":null,"source":{"id":"https://openalex.org/S116025658","display_name":"American Journal of Psychiatry","issn_l":"0002-953X","issn":["0002-953X","1535-7228"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","erih-plus","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310316602","host_organization_name":"American Psychiatric Association","host_organization_lineage":["https://openalex.org/P4310316602"],"host_organization_lineage_names":["American Psychiatric Association"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"American Journal of Psychiatry","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2463342811"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5053230942","display_name":"Amit Anand","orcid":"https://orcid.org/0000-0003-1016-6904","observed_orcids":["https://orcid.org/0000-0003-1016-6904"]},"institutions":[{"id":"https://openalex.org/I4210155461","display_name":"Connecticut Mental Health Center","ror":"https://ror.org/0569bbe51","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210155461"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"A Anand","raw_affiliation_strings":["Clinical Neuroscience Research Unit, Connecticut Mental Health Center, New Haven"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Neuroscience Research Unit, Connecticut Mental Health Center, New Haven","institution_ids":["https://openalex.org/I4210155461"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111886018","display_name":"Dennis S. Charney","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"D S Charney","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054838334","display_name":"Pedro L. Delgado","orcid":"https://orcid.org/0000-0002-9183-841X","observed_orcids":["https://orcid.org/0000-0002-9183-841X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"P L Delgado","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019555383","display_name":"Christopher J. McDougle","orcid":"https://orcid.org/0000-0002-6229-9293","observed_orcids":["https://orcid.org/0000-0002-6229-9293"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"C J McDougle","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039312313","display_name":"George R. Heninger","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"G R Heninger","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5108409294","display_name":"L H Price","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"L H Price","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":2.6334,"has_fulltext":false,"cited_by_count":57,"citation_normalized_percentile":{"value":0.88602151,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":95},"biblio":{"volume":"151","issue":"11","first_page":"1626","last_page":"1630"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10529","display_name":"Stress Responses and Cortisol","score":0.8256999850273132,"subfield":{"id":"https://openalex.org/subfields/2802","display_name":"Behavioral Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10529","display_name":"Stress Responses and Cortisol","score":0.8256999850273132,"subfield":{"id":"https://openalex.org/subfields/2802","display_name":"Behavioral Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":0.11100000143051147,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.03550000116229057,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/major-depressive-disorder","display_name":"major depressive disorder","score":0.8009999990463257},{"id":"https://openalex.org/keywords/m-chlorophenylpiperazine","display_name":"m-chlorophenylpiperazine","score":0.9829999804496765},{"id":"https://openalex.org/keywords/serotonin-receptor-agonists","display_name":"serotonin receptor agonists","score":0.7269999980926514},{"id":"https://openalex.org/keywords/growth-hormone-response","display_name":"growth hormone response","score":0.9120000004768372},{"id":"https://openalex.org/keywords/prolactin","display_name":"prolactin","score":0.953000009059906},{"id":"https://openalex.org/keywords/cortisol","display_name":"cortisol","score":0.9980000257492065},{"id":"https://openalex.org/keywords/neuroendocrine-response","display_name":"neuroendocrine response","score":0.8519999980926514},{"id":"https://openalex.org/keywords/mood","display_name":"mood","score":0.7870000004768372}],"concepts":[{"id":"https://openalex.org/C37000724","wikidata":"https://www.wikidata.org/wiki/Q50430226","display_name":"Serotonergic","level":4,"score":0.8846884965896606},{"id":"https://openalex.org/C2779064019","wikidata":"https://www.wikidata.org/wiki/Q66590068","display_name":"Prolactin","level":3,"score":0.808593213558197},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.7090960741043091},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.6794441938400269},{"id":"https://openalex.org/C2775864247","wikidata":"https://www.wikidata.org/wiki/Q167934","display_name":"Serotonin","level":3,"score":0.6076715588569641},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.5753718018531799},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.5666771531105042},{"id":"https://openalex.org/C2780733359","wikidata":"https://www.wikidata.org/wiki/Q331769","display_name":"Mood","level":2,"score":0.5354668498039246},{"id":"https://openalex.org/C2776867660","wikidata":"https://www.wikidata.org/wiki/Q1814941","display_name":"Depression (economics)","level":2,"score":0.4803425073623657},{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.4414524435997009},{"id":"https://openalex.org/C53910766","wikidata":"https://www.wikidata.org/wiki/Q238516","display_name":"5-HT receptor","level":4,"score":0.434286504983902},{"id":"https://openalex.org/C2777397205","wikidata":"https://www.wikidata.org/wiki/Q275792","display_name":"Saline","level":2,"score":0.43072134256362915},{"id":"https://openalex.org/C2778709874","wikidata":"https://www.wikidata.org/wiki/Q190875","display_name":"Hydrocortisone","level":2,"score":0.42078667879104614},{"id":"https://openalex.org/C2909992730","wikidata":"https://www.wikidata.org/wiki/Q7455050","display_name":"Serotonin Agonist","level":5,"score":0.4153982996940613},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.40293943881988525},{"id":"https://openalex.org/C71315377","wikidata":"https://www.wikidata.org/wiki/Q11364","display_name":"Hormone","level":2,"score":0.3667653799057007},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.17151984572410583},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.1545918881893158},{"id":"https://openalex.org/C139719470","wikidata":"https://www.wikidata.org/wiki/Q39680","display_name":"Macroeconomics","level":1,"score":0.0},{"id":"https://openalex.org/C162324750","wikidata":"https://www.wikidata.org/wiki/Q8134","display_name":"Economics","level":0,"score":0.0},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000339","descriptor_name":"Affect","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D003866","descriptor_name":"Depressive Disorder","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D003866","descriptor_name":"Depressive Disorder","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":false},{"descriptor_ui":"D003866","descriptor_name":"Depressive Disorder","qualifier_ui":"Q000523","qualifier_name":"psychology","is_major_topic":false},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006854","descriptor_name":"Hydrocortisone","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D007262","descriptor_name":"Infusions, Intravenous","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010879","descriptor_name":"Piperazines","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D010879","descriptor_name":"Piperazines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D010919","descriptor_name":"Placebos","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011388","descriptor_name":"Prolactin","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D011985","descriptor_name":"Receptors, Serotonin","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D011985","descriptor_name":"Receptors, Serotonin","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false},{"descriptor_ui":"D012701","descriptor_name":"Serotonin","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false},{"descriptor_ui":"D013006","descriptor_name":"Growth Hormone","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D015415","descriptor_name":"Biomarkers","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017366","descriptor_name":"Serotonin Receptor Agonists","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D017366","descriptor_name":"Serotonin Receptor Agonists","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1176/ajp.151.11.1626","doi":"https://doi.org/10.1176/ajp.151.11.1626","is_oa":false,"landing_page_url":"https://doi.org/10.1176/ajp.151.11.1626","pdf_url":null,"source":{"id":"https://openalex.org/S116025658","display_name":"American Journal of Psychiatry","issn_l":"0002-953X","issn":["0002-953X","1535-7228"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","erih-plus","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310316602","host_organization_name":"American Psychiatric Association","host_organization_lineage":["https://openalex.org/P4310316602"],"host_organization_lineage_names":["American Psychiatric Association"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"American Journal of Psychiatry","raw_type":"journal-article"},{"id":"pmid:7943451","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/7943451","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The American journal of psychiatry","raw_type":"Clinical Trial"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9940000176429749}],"study_designs":[],"awards":[{"id":"https://openalex.org/G3674930279","display_name":"MONOAMINE RECEPTOR SENSITIVITY AND ANTIDEPRESSANT DRUGS","funder_award_id":"R01MH036229","funder_id":"https://openalex.org/F4320337346","funder_display_name":"National Institute of Mental Health"},{"id":"https://openalex.org/G7324053004","display_name":"NEUROBIOLOGICAL BASIS OF MAJOR PSYCHIATRIC DISORDERS","funder_award_id":"P01MH025642","funder_id":"https://openalex.org/F4320337346","funder_display_name":"National Institute of Mental Health"},{"id":"https://openalex.org/G744663869","display_name":null,"funder_award_id":"MH30929","funder_id":"https://openalex.org/F4320337346","funder_display_name":"National Institute of Mental Health"}],"funders":[{"id":"https://openalex.org/F4320337346","display_name":"National Institute of Mental Health","ror":"https://ror.org/04xeg9z08"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":20,"referenced_works":["https://openalex.org/W62739187","https://openalex.org/W70957178","https://openalex.org/W186166836","https://openalex.org/W1966561484","https://openalex.org/W1991708936","https://openalex.org/W1993015131","https://openalex.org/W1996140740","https://openalex.org/W2044323467","https://openalex.org/W2052474780","https://openalex.org/W2075278843","https://openalex.org/W2077343282","https://openalex.org/W2079632266","https://openalex.org/W2092356890","https://openalex.org/W2114772172","https://openalex.org/W2157574960","https://openalex.org/W2163145678","https://openalex.org/W2169721356","https://openalex.org/W2345595328","https://openalex.org/W2883849285","https://openalex.org/W4231773694"],"related_works":["https://openalex.org/W2030625904","https://openalex.org/W2345595328","https://openalex.org/W2043591312","https://openalex.org/W2155624304","https://openalex.org/W2039033171","https://openalex.org/W2064824224","https://openalex.org/W2023298760","https://openalex.org/W2339156669","https://openalex.org/W1976899193","https://openalex.org/W1965018692"],"abstract_inverted_index":{"OBJECTIVE:":[0],"This":[1],"double-blind":[2],"study":[3],"was":[4,67],"undertaken":[5],"to":[6,24,84,131,169],"compare":[7],"central":[8],"serotonergic":[9,166],"function":[10],"in":[11,137,140,155,175],"depressed":[12,89,149],"patients":[13,39,90],"and":[14,21,44,77,96,106,142],"healthy":[15],"comparison":[16,47,102],"subjects":[17,54],"by":[18],"examining":[19],"neuroendocrine":[20,158],"mood":[22],"responses":[23],"intravenous":[25,57],"infusion":[26,58],"of":[27,59,71,121,147,153,164],"the":[28,53,101,107,115,127,148,156,162],"serotonin":[29],"agonist":[30],"m-chlorophenylpiperazine":[31],"(mCPP).":[32],"METHOD:":[33],"The":[34,88,151],"participants":[35],"were":[36,82],"20":[37],"drug-free":[38],"with":[40,123],"DSM-III-R":[41],"major":[42],"depression":[43,141],"18":[45],"healty":[46],"subjects.":[48],"After":[49],"an":[50,56],"overnight":[51],"fast,":[52],"received":[55],"mCPP,":[60],"0.1":[61],"mg/kg,":[62],"or":[63],"placebo":[64],"saline.":[65],"Blood":[66],"obtained":[68],"for":[69],"measurement":[70],"serum":[72],"prolactin,":[73,104],"growth":[74],"hormone":[75],"(GH),":[76],"cortisol.":[78],"Visual":[79],"analogue":[80],"scales":[81],"used":[83],"assess":[85],"mood.":[86],"RESULTS:":[87],"had":[91],"a":[92,135,145],"blunted":[93,128],"GH":[94,129,138],"response":[95,130],"felt":[97],"less":[98],"drowsy":[99],"than":[100],"subjects;":[103],"cortisol,":[105],"remaining":[108],"behavioral":[109],"ratings":[110],"showed":[111],"no":[112],"differences":[113,154],"between":[114],"two":[116],"groups.":[117],"CONCLUSIONS:":[118],"In":[119],"light":[120],"findings":[122],"other":[124,157],"provocative":[125],"agents,":[126],"mCPP":[132,170],"may":[133,171],"reflect":[134],"defect":[136],"production":[139],"could":[143],"be":[144,172],"marker":[146],"state.":[150],"lack":[152],"variables":[159],"suggests":[160],"that":[161],"functioning":[163],"postsynaptic":[165],"receptors":[167],"responsive":[168],"relatively":[173],"intact":[174],"depression.":[176]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2463342811","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-07-22T00:00:00"}
